HLN.L vs JNJ
HLN.L: A leading global consumer healthcare business managing a portfolio of world-class brands in pain relief, oral health, and wellness. JNJ: Johnson & Johnson is a global leader in innovative pharmaceuticals and advanced medical technology dedicated to addressing the world's most complex health challenges.
Side-by-side fundamentals
| Metric | HLN.L | JNJ | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £3.62 | $257.59 | |
| Market cap as of 2026-08-06 | n/a | $620.8B | |
| P/E as of 2026-08-06 | n/a | 29.51 | |
| PEG as of 2026-08-06 | n/a | 3.39 | |
| Net margin as of 2026-08-06 | n/a | +21.5% | |
| Gross margin as of 2026-08-06 | n/a | +68.0% | |
| Operating margin as of 2026-08-06 | n/a | +25.7% | |
| ROE as of 2026-08-06 | n/a | +25.7% | |
| ROA as of 2026-08-06 | n/a | +10.6% | |
| Debt / equity as of 2026-08-06 | n/a | 0.58 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | +8.1% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +6.2% | |
| Dividend yield as of 2026-08-06 | n/a | +2.1% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-06 | n/a | 0.20 | |
| 1-year return as of 2026-08-03 close | -0.8% | +50.9% | JNJ higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.